Antibiotic residues, including tetracyclines, macrolides, and erythromycin, have been detected in commercial honey, potentially stemming from sources such as direct beekeeping practices for disease treatment or environmental contamination. These substances may be introduced when antibiotics are used to control bacterial infections in bee colonies, or through exposure to contaminated water, soil, or nearby agricultural activity.
The presence of antibiotic residues in honey raises important concerns regarding food safety and public health. For consumers, potential risks include allergic reactions, particularly in individuals with known sensitivities to specific antibiotics. Even low-level, chronic exposure may also contribute to the broader global issue of antimicrobial resistance, where bacteria evolve to withstand antibiotic treatments, reducing their effectiveness in both human and veterinary medicine.
In addition to health implications, the detection of residues can have significant economic and regulatory consequences. Honey that exceeds established maximum residue limits (MRLs) may be rejected from markets, leading to financial losses and reputational damage for producers and exporters. As international standards for food safety continue to tighten, ensuring compliance has become increasingly important.
This underscores the critical importance of routine honey testing, robust residue monitoring programmes, and adherence to good beekeeping practices. Implementing effective quality control measures helps to identify contamination early, maintain product integrity, and protect consumer trust. By prioritising regular screening and responsible antibiotic use, producers can support safer food supply chains and meet the expectations of both regulators and consumers worldwide.
